Laub Ronald MD Colorado Springs, CO - 80909

Laub Ronald MD is categorized under Internal Medicine Doctors in Colorado Springs, CO and active since 2010.

Laub Ronald MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Ronald Laub at the company’s single location by writing to 3010 North Circle Drive # 202, Colorado Springs, Colorado CO 80909 or by phoning (719) 228-9440. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Laub Ronald MD
Contact Person: Ronald Laub
Address: 3010 North Circle Drive # 202, Colorado Springs, Colorado 80909
Phone Number: (719) 228-9440
Website Address: coloradopain.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Laub Ronald MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Ronald Laub for inquiries that concern Laub Ronald MD by calling the company number (719) 228-9440, as your correspondence is most welcome. Additionally, the physical location of the single location of Laub Ronald MD can be found at the coordinates 38.87358,-104.79266 as well as the street address 3010 North Circle Drive # 202 in Colorado Springs, Colorado 80909.

For its online presence, you may visit Laub Ronald MD’s website at coloradopain.com and engage with its social media outlets through on Twitter and on Facebook.